The Effect of a Single Course of α-2B-Interferon in Patients with Hiv-Related and Chronic Idiopathic Immune Thrombocytopenia

References

• McVerry B A. Management of idiopathic thrombocytopenic purpura in adults. B J Haemat 1985; 59: 203–208
   PubMed Web of Science ®Google Scholar
• Di Fino S M, Lachant N A, Kirshner J J, Gottlieb A J. Adult idiopathic thrombocytopenic purpura. Clinical response to therapy. Am J Med 1980; 69: 430–442
   PubMed Web of Science ®Google Scholar
• Fabris F, Zanatta N, Casonato A, Randi M L, Luzzatto G, Girolami A. Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation. Acta Haemat 1989; 81: 28–33
   PubMed Web of Science ®Google Scholar
• Scadden D T, Zon L, Groopman J E. Pathophysiology and management of HIV-associated hematological disorders. Blood 1989; 74: 1455–1463
   PubMed Web of Science ®Google Scholar
• Rossi E, Damasio E, Teragna A, Mazzarello G, Spriano M, Anselmo M. HIV-related thrombocytopenia: a therapeutical update. Haematologica 1991; 76: 141–149
   PubMed Web of Science ®Google Scholar
• Landonio G L, Galli M, Nosari A, Lazzarin A, Cipriani D, Crocchiolo P, Voltolin L, Lrato L, De Cataldo F, Moroni M. HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-tern form follow-up, and pathogenetic evaluation. AIDS 1990; 4: 29–34
   PubMed Web of Science ®Google Scholar
• Manoharan A. Treatment of refractory idiopathic thrombocytopenic purpura in adults. B J Haemat 1991; 79: 143–147
   PubMed Web of Science ®Google Scholar
• Bussel B, Graziano J N, Kimberly R P, Pahwa S, Aledort L. Intravenous anti-D treatment of immune thrombocytopenia purpura: analysis of efficacy. toxicity and mechanism of effect. Blood 1991; 17: 1884–1893
   Google Scholar
• Rossi E, Vinmercati R, Damasio E, Terragna A, Mazzarello G, Anselmo M, Dodi F, Del Bono V, Pagano G, Gualandi F, Sogno G, Queirolo M A, Pizzaferri R, Marmont A. Treatment of idiophatic thrombocytopenic purpura in HIV positive patients with rhesus antibodies (anti-D). Haematologica 1987; 72: 529–532
   PubMed Web of Science ®Google Scholar
• Pollak A N, Janinis I, Green D. Successful intravenous immu-noglobulins therapy for human immunodeficiency virus-associated thrombocytopenia. Arch Int Med 1988; 148: 695–697
   PubMedGoogle Scholar
• Barbui T, Cortellazzo S, Minetti B, Galli M, Buelli M. Does splenectomy enhance risk of AIDS in HIV-positive patient with chronic thrombocytopenia. Lancet 1987; 2: 342–343
   PubMed Web of Science ®Google Scholar
• Hymes K, Greene J B, Karpatkin S. The effect of azido thymid-ine on HIV-related thrombocytopenia. N Eng J Med 1988; 25: 516–517
   Google Scholar
• The Swiss group for clinical studies on the acquired immunodeficiency syndrome (AIDS) Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). Ann Int Med 1988; 109: 718–721
   PubMed Web of Science ®Google Scholar
• Ellis M E, Neal K R, Leen C LS. Alpha-2b recombinant interferon in HIV associated thrombocytopenia. Br Med J 1987; 295: 1519
   PubMedGoogle Scholar
• Lever A ML, Brook M G, Yap I, Thomas H C. Treatment of thrombocytopenia with alpha interferon. Br Med J 1987; 295: 1519–1520
   PubMedGoogle Scholar
• Garavelli P L. Treatment of HIV-associated thrombocytopenia. Haematologica 1989; 74: 412
   PubMed Web of Science ®Google Scholar
• Proctor S J, Jackson G, Carey P, Stark A, Finney R, Saunders P, Summerfield G, Maharaj A, Youart A. Improvement of platelet counts in steroids-unresponsive idiopathic immune thrombo-cytopenic purpura after dhort-course iherapy with recombinant alpha-2b Interferon. Blood 1989; 74: 1894–1897
   PubMed Web of Science ®Google Scholar
• Bellucci S, Bordessoul D, Coiffier B, Tabah I. Interferon a-2b therapy in adult thrombocytopenic purpura (ITP). Br J Haematol 1989; 13: 578–579
   Google Scholar
• Molica S, Santoro R, Muleo G. Letter to editor: Recombinant a-2b Interferon in refractory idiopathic immune thrombocytopenia. Am J Haematol 1991; 36: 297–298
   PubMed Web of Science ®Google Scholar
• Hurtado R, Pita L, Lopez Karpovitch X, Cardenas R, Piedras J, Carrillo S, Labardini I. Recombinant Interferon alfa-2b in refractory idiopathic immune thrombocytopenia. Blood 1990; 15: 1744–1745
   Google Scholar
• Redfield R R, Wright D C, Tramont E C. The Walter-Reed staging classification of HTLVIII/LAV infection. N Eng J Med 1986; 9: 131–132
   Google Scholar
• Wadenvik H, Kutti J, Ridell B, Revesz P, Jacobsson S, Magnusson B, Westin J, Vilen L. The effect of a-Interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia. Blood 1991; 77: 2103–2108
   PubMed Web of Science ®Google Scholar
• Matthey F, Ardeman S, Jones L, Newland A C. Bleeding in immune thrombocytopenic purpura after alpha-interferon. Lancet 1990; 335: 471–472
   PubMed Web of Science ®Google Scholar
• Abdi A E, Brien W, Venner P M. Autoimmune thrombocytopenia related to interferon therapy. Scan J Haematol 1986; 36: 515–519
   PubMedGoogle Scholar
• Stiehm E R, Kronenberg L H, Rosenblatt H M, Bryson Y, Merigan T C. Interferon: immunobiology and clinical significance. Ann Int Med 1982; 96: 80–83
   PubMed Web of Science ®Google Scholar
• Karpatkin S. Immunologic thrombocytopenic purpura in HIV-seropositive homosexual, narcotic addicts and hemophiliacs. Seminar in Hematology 1988; 25: 219–229
   PubMed Web of Science ®Google Scholar
• Sonnenfeld G. Effect on interferon on antibodies formation. “Interferon and the immune system”, J Vilcek, F De Mayer. Elsevier Science Publishers BV. 1984; 85–88
   Google Scholar
• Semple J W, Bruce S, Freedman J. Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura. Am J Haematol 1991; 37: 258–262
   PubMed Web of Science ®Google Scholar